WEKO3
インデックスリンク
アイテム
{"_buckets": {"deposit": "5f90f7d5-70cf-4f4f-b337-662e3661c08a"}, "_deposit": {"created_by": 3, "id": "13787", "owners": [3], "pid": {"revision_id": 0, "type": "depid", "value": "13787"}, "status": "published"}, "_oai": {"id": "oai:kanazawa-u.repo.nii.ac.jp:00013787", "sets": ["1134"]}, "author_link": ["23181", "23178", "23176", "23182", "23177", "23180", "22754", "62", "585", "23179", "520", "225"], "item_4_biblio_info_8": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2012-06-01", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "6", "bibliographicPageEnd": "534", "bibliographicPageStart": "528", "bibliographicVolumeNumber": "39", "bibliographic_titles": [{"bibliographic_title": "Clinical and Experimental Pharmacology and Physiology"}]}]}, "item_4_description_21": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Few studies have evaluated the pharmacokinetics of rapid-acting insulin analogues in patients with Type 2 diabetes, especially under clinical conditions. The aim of the present study was to assess both the pharmacokinetics and pharmacodynamics of insulin aspart in Type 2 diabetic patients who were being treated with the analogue alone. Meal tolerance tests with and without self-injection of a customary dose of insulin aspart (0.05-0.22 U/kg) were conducted in 20 patients in a randomized cross-over study. The dose of insulin aspart (per bodyweight) was significantly correlated with both the maximum concentration (r 2 = 0.59; P \u003c 0.01) and area under the concentration-time curve for insulin aspart (r 2 = 0.53; P \u003c 0.01). However, the time to maximum concentration (T max), which varied widely from \u003c 60 to ≥ 120 min, was not associated with either dosage (r 2 = 0.02; P = 0.51) or body mass index (r 2 = 0.02; P = 0.57). Injection of insulin aspart exacerbated delayed hyperinsulinaemia after meal loading, mainly in patients with T max ≥ 120 min. With regard to pharmacodynamics, insulin aspart had favourable effects on postprandial hyperglycaemia, hyperglucagonaemia and hyperlipidaemia. The T max for this insulin analogue differed greatly between individuals and delayed hyperinsulinaemia was particularly exacerbated in patients with higher T max values. Identification of the factors contributing to interindividual variation in the absorption lag time is essential for improving the efficacy and safety of insulin aspart. © 2012 The Authors. Clinical and Experimental Pharmacology and Physiology © 2012 Blackwell Publishing Asia Pty Ltd.", "subitem_description_type": "Abstract"}]}, "item_4_publisher_17": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "Blackwell"}]}, "item_4_relation_12": {"attribute_name": "DOI", "attribute_value_mlt": [{"subitem_relation_type": "isVersionOf", "subitem_relation_type_id": {"subitem_relation_type_id_text": "10.1111/j.1440-1681.2012.05708.x", "subitem_relation_type_select": "DOI"}}]}, "item_4_source_id_11": {"attribute_name": "NCID", "attribute_value_mlt": [{"subitem_source_identifier": "AA00607727", "subitem_source_identifier_type": "NCID"}]}, "item_4_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "0305-1870", "subitem_source_identifier_type": "ISSN"}]}, "item_4_version_type_25": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_version_resource": "http://purl.org/coar/version/c_ab4af688f83e57aa", "subitem_version_type": "AM"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Ando, Hitoshi"}], "nameIdentifiers": [{"nameIdentifier": "23176", "nameIdentifierScheme": "WEKO"}, {"nameIdentifier": "50382875", "nameIdentifierScheme": "金沢大学研究者情報", "nameIdentifierURI": "http://ridb.kanazawa-u.ac.jp/public/detail.php?kaken=50382875"}, {"nameIdentifier": "50382875", "nameIdentifierScheme": "研究者番号", "nameIdentifierURI": "https://nrid.nii.ac.jp/nrid/1000050382875"}]}, {"creatorNames": [{"creatorName": "Kurita, Seiichiro"}], "nameIdentifiers": [{"nameIdentifier": "22754", "nameIdentifierScheme": "WEKO"}, {"nameIdentifier": "20436819", "nameIdentifierScheme": "研究者番号", "nameIdentifierURI": "https://nrid.nii.ac.jp/nrid/1000020436819"}]}, {"creatorNames": [{"creatorName": "Shimizu, Akiko"}], "nameIdentifiers": [{"nameIdentifier": "23177", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kato, Ken-ichiro"}], "nameIdentifiers": [{"nameIdentifier": "23178", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ishikura, Kazuhide"}], "nameIdentifiers": [{"nameIdentifier": "23179", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Taji, Koumei"}], "nameIdentifiers": [{"nameIdentifier": "23180", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Uno, Masafumi"}], "nameIdentifiers": [{"nameIdentifier": "23181", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Takeshita, Yumie"}], "nameIdentifiers": [{"nameIdentifier": "585", "nameIdentifierScheme": "WEKO"}, {"nameIdentifier": "40507042", "nameIdentifierScheme": "金沢大学研究者情報", "nameIdentifierURI": "http://ridb.kanazawa-u.ac.jp/public/detail.php?kaken=40507042"}, {"nameIdentifier": "40507042", "nameIdentifierScheme": "研究者番号", "nameIdentifierURI": "https://nrid.nii.ac.jp/nrid/1000040507042"}]}, {"creatorNames": [{"creatorName": "Misu, Hirofumi"}], "nameIdentifiers": [{"nameIdentifier": "520", "nameIdentifierScheme": "WEKO"}, {"nameIdentifier": "80447680", "nameIdentifierScheme": "金沢大学研究者情報", "nameIdentifierURI": "http://ridb.kanazawa-u.ac.jp/public/detail.php?kaken=80447680"}, {"nameIdentifier": "80447680", "nameIdentifierScheme": "研究者番号", "nameIdentifierURI": "https://nrid.nii.ac.jp/nrid/1000080447680"}]}, {"creatorNames": [{"creatorName": "Fujimura, Akio"}], "nameIdentifiers": [{"nameIdentifier": "23182", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kaneko, Shuichi"}], "nameIdentifiers": [{"nameIdentifier": "62", "nameIdentifierScheme": "WEKO"}, {"nameIdentifier": "60185923", "nameIdentifierScheme": "e-Rad", "nameIdentifierURI": "https://kaken.nii.ac.jp/ja/search/?qm=60185923"}, {"nameIdentifier": "60185923", "nameIdentifierScheme": "金沢大学研究者情報", "nameIdentifierURI": "http://ridb.kanazawa-u.ac.jp/public/detail.php?kaken=60185923"}, {"nameIdentifier": "60185923", "nameIdentifierScheme": "研究者番号", "nameIdentifierURI": "https://nrid.nii.ac.jp/nrid/1000060185923"}]}, {"creatorNames": [{"creatorName": "Takamura, Toshinari"}], "nameIdentifiers": [{"nameIdentifier": "225", "nameIdentifierScheme": "WEKO"}, {"nameIdentifier": "00324111", "nameIdentifierScheme": "e-Rad", "nameIdentifierURI": "https://kaken.nii.ac.jp/ja/search/?qm=00324111"}, {"nameIdentifier": "00324111", "nameIdentifierScheme": "金沢大学研究者情報", "nameIdentifierURI": "http://ridb.kanazawa-u.ac.jp/public/detail.php?kaken=00324111"}, {"nameIdentifier": "00324111", "nameIdentifierScheme": "研究者番号", "nameIdentifierURI": "https://nrid.nii.ac.jp/nrid/1000000324111"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2017-10-03"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "ME-PR-ANDO-H-528.pdf", "filesize": [{"value": "1.3 MB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 1300000.0, "url": {"label": "ME-PR-ANDO-H-528.pdf", "url": "https://kanazawa-u.repo.nii.ac.jp/record/13787/files/ME-PR-ANDO-H-528.pdf"}, "version_id": "78ca76bc-65ad-489c-b0ac-778939990b4b"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "Delayed hyperinsulinaemia", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Glucagon", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Insulin aspart", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Postprandial hyperlipidaemia", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Rapid-acting insulin analogues", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Pharmacokinetics and pharmacodynamics of insulin aspart in patients with Type 2 diabetes: Assessment using a meal tolerance test under clinical conditions", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Pharmacokinetics and pharmacodynamics of insulin aspart in patients with Type 2 diabetes: Assessment using a meal tolerance test under clinical conditions"}]}, "item_type_id": "4", "owner": "3", "path": ["1134"], "permalink_uri": "http://hdl.handle.net/2297/31973", "pubdate": {"attribute_name": "公開日", "attribute_value": "2017-10-03"}, "publish_date": "2017-10-03", "publish_status": "0", "recid": "13787", "relation": {}, "relation_version_is_last": true, "title": ["Pharmacokinetics and pharmacodynamics of insulin aspart in patients with Type 2 diabetes: Assessment using a meal tolerance test under clinical conditions"], "weko_shared_id": -1}
Pharmacokinetics and pharmacodynamics of insulin aspart in patients with Type 2 diabetes: Assessment using a meal tolerance test under clinical conditions
http://hdl.handle.net/2297/31973
http://hdl.handle.net/2297/31973255e2b4a-d69c-4ef9-a7fc-9a2fc72d28f6
名前 / ファイル | ライセンス | アクション |
---|---|---|
ME-PR-ANDO-H-528.pdf (1.3 MB)
|
|
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2017-10-03 | |||||
タイトル | ||||||
タイトル | Pharmacokinetics and pharmacodynamics of insulin aspart in patients with Type 2 diabetes: Assessment using a meal tolerance test under clinical conditions | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
著者 |
Ando, Hitoshi
× Ando, Hitoshi× Kurita, Seiichiro× Shimizu, Akiko× Kato, Ken-ichiro× Ishikura, Kazuhide× Taji, Koumei× Uno, Masafumi× Takeshita, Yumie× Misu, Hirofumi× Fujimura, Akio× Kaneko, Shuichi× Takamura, Toshinari |
|||||
書誌情報 |
Clinical and Experimental Pharmacology and Physiology 巻 39, 号 6, p. 528-534, 発行日 2012-06-01 |
|||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 0305-1870 | |||||
NCID | ||||||
収録物識別子タイプ | NCID | |||||
収録物識別子 | AA00607727 | |||||
DOI | ||||||
関連タイプ | isVersionOf | |||||
識別子タイプ | DOI | |||||
関連識別子 | 10.1111/j.1440-1681.2012.05708.x | |||||
出版者 | ||||||
出版者 | Blackwell | |||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Few studies have evaluated the pharmacokinetics of rapid-acting insulin analogues in patients with Type 2 diabetes, especially under clinical conditions. The aim of the present study was to assess both the pharmacokinetics and pharmacodynamics of insulin aspart in Type 2 diabetic patients who were being treated with the analogue alone. Meal tolerance tests with and without self-injection of a customary dose of insulin aspart (0.05-0.22 U/kg) were conducted in 20 patients in a randomized cross-over study. The dose of insulin aspart (per bodyweight) was significantly correlated with both the maximum concentration (r 2 = 0.59; P < 0.01) and area under the concentration-time curve for insulin aspart (r 2 = 0.53; P < 0.01). However, the time to maximum concentration (T max), which varied widely from < 60 to ≥ 120 min, was not associated with either dosage (r 2 = 0.02; P = 0.51) or body mass index (r 2 = 0.02; P = 0.57). Injection of insulin aspart exacerbated delayed hyperinsulinaemia after meal loading, mainly in patients with T max ≥ 120 min. With regard to pharmacodynamics, insulin aspart had favourable effects on postprandial hyperglycaemia, hyperglucagonaemia and hyperlipidaemia. The T max for this insulin analogue differed greatly between individuals and delayed hyperinsulinaemia was particularly exacerbated in patients with higher T max values. Identification of the factors contributing to interindividual variation in the absorption lag time is essential for improving the efficacy and safety of insulin aspart. © 2012 The Authors. Clinical and Experimental Pharmacology and Physiology © 2012 Blackwell Publishing Asia Pty Ltd. | |||||
著者版フラグ | ||||||
出版タイプ | AM | |||||
出版タイプResource | http://purl.org/coar/version/c_ab4af688f83e57aa |